metastatic hepatocellular carcinoma

Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study
Benzinga
Mon, 05/1/23 - 10:22 am
Tempest Therapeutics
TPST-1120
clinical trials
metastatic hepatocellular carcinoma
Roche nabs frontline OK for Avastin/Tecentriq in common liver cancer, besting an old Bayer drug
Endpoints
Mon, 06/1/20 - 10:24 am
Roche
Avastin
Tecentriq
metastatic hepatocellular carcinoma
liver cancer
FDA